Unlike any other neuromodulation technique, HD-tDCS is non-invasive, targeted, and can leverage the therapeutic potential, convenience, safety, and cost-advantages of tDCS. Soterix medical is the exclusive manufacturer and provider of HD-tDCS technology. In 9-channel (M×N-9) every M×N system allows full control of electrode placement and current, producing unprecedented non-invasive targeting....

MxN HD-tDCS (9 Channel)

This product is limited to researchers or medical doctors. Please contact us for a quote if you are interested in this product.

Unlike any other neuromodulation technique, HD-tDCS is non-invasive, targeted, and can leverage the therapeutic potential, convenience, safety, and cost-advantages of tDCS. Soterix medical is the exclusive manufacturer and provider of HD-tDCS technology. In 9-channel (M×N-9) every M×N system allows full control of electrode placement and current, producing unprecedented non-invasive targeting. Exclusive control technology allows true independent current control and monitoring.

All M×N systems are HD-Targets and HD-Explore enabled allowing investigators to leverage automatic and manual dose optimization. Combine M×N with Soterix Medical Custom modeling for individually optimized treatment.

Leveraging exclusive Soterix Medical HD-electrodes, the M×N system can be configured for effective DC stimulation without sensation in most subjects. Study design benefits from the first full sensation matched sham protocols. Adapt stimulation for susceptible populations and individualize treatment for efficacy and safety.

Feel free to contact our engineers at Caputron to assist you with your endeavors, we would love to help!